Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
DraftKings is down 20% over the past month, Q3 results are three weeks away, and analysts are still reaching for their red pens.
Since the prior note was published on October 7, the target-cutting has continued. Citigroup's James Hardiman moved his target from $32 to $28 on October 12, keeping a Buy. Susquehanna trimmed to $27 from $33 the day before, also holding its positive rating. The pattern across the past fortnight is consistent: firms are staying constructive in stance but marking numbers lower in each revision. The consensus mean now sits at $34.34, against a closing price of $19.72. That 74% implied return reflects genuine long-term conviction rather than near-term optimism, and a gap that wide typically matters less as a price signal than as an indicator of how far sentiment has already moved from the operating fundamentals. Bank of America's upgrade to Buy on October 5, at a $27 target, is the one directional outlier in an otherwise uniform wave of downgrades to estimates. The factor scores add some nuance: forward EPS growth ranks in the 92nd percentile and 30-day EPS momentum ranks 91st, meaning the revisions lower are happening from a base that has been improving faster than most peers.
The bull-bear split is sharpest on the investment cycle. Bulls point to DraftKings' prediction-market vertical, the DraftKings Predictions and DKeX exchange layer, as a route to structurally higher margins once the build phase peaks. The company has added 4 million app downloads since June and holds monthly active user share running around 1,000 basis points ahead of where it was. Gross margins are expected to converge toward 60 to 70%, with EBITDA margins ultimately targeting 50%. Bears focus on the cost of getting there: net PredictionMarket spend is now modelled at around $400 million, double the original guidance, and full-year 2026 EBITDA is tracking toward $532 million, a 14% decline from 2025. The $400 million overrun is the single most cited reason for the wave of target reductions.
Short positioning is building modestly but is far from the defining story. SI ticked up 2% on the week to 7.7% of the free float, a steady grind higher from the 7.5% level noted in the prior note rather than a sharp acceleration. The borrow market is extremely loose. Availability is running at 2,407%, meaning lenders have roughly 25 shares available for every one already borrowed, and the 52-week low availability reading was 462%, so even the tightest moment of the past year left plenty of room. Borrowing costs doubled on the week to 0.38%, but at that absolute level the move is statistical noise, not a squeeze signal. The ORTEX short score sits at 45.8, in the lower half of the range, consistent with a stock that is modestly shorted but nowhere near a high-conviction bear trade from the lending-market perspective. Options tell the same calm story: the put/call ratio is 0.33, just below its 20-day average of 0.33, and well beneath the 52-week high of 0.62. There is no defensive scramble in the options market.
One institutional development worth flagging is the arrival of CIBC on the register. The Canadian Imperial Bank of Commerce filed a Schedule 13G in August disclosing a 7.3% stake, making it the largest reported holder in the snapshot. AQR Capital disclosed a 5.9% position in the same period. Both are passive filings, carrying no activist intent, but the entries are notable given the stock's decline: new 5%-plus holders arriving at 20-year lows in the share price is typically a flow dynamic rather than a strategic signal, though it does add name-brand institutional weight to the register. As with all 13D/G disclosures, positions reflect the stake as last reported around the 5% threshold; holders dropping below that level may not file again.
Earnings land on November 5. The last two quarterly prints each produced a single-day move above 10% and a five-day move above 17%, both to the upside. Whether the market frames the next release around the investment overshoot or the underlying OSB and iGaming trajectory, which management says remains on track for $1 billion-plus of EBITDA standalone, is the question that will decide whether that pattern holds.
See the live data behind this article on ORTEX.
Open DKNG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
